Ipsen S.A. (IPSEY)
OTCMKTS · Delayed Price · Currency is USD
31.14
+0.08 (0.26%)
Aug 12, 2025, 12:10 PM EDT
Ipsen Revenue
Ipsen had revenue of 1.94B EUR in the half year ending June 30, 2025, with 19.35% growth. This brings the company's revenue in the last twelve months to 3.76B, up 11.54% year-over-year. In the year 2024, Ipsen had annual revenue of 3.57B with 8.11% growth.
Revenue (ttm)
3.76B EUR
Revenue Growth
+11.54%
P/S Ratio
2.33
Revenue / Employee
701.72K EUR
Employees
5,358
Market Cap
10.29B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.57B | 268.10M | 8.11% |
| Dec 31, 2023 | 3.31B | 150.00M | 4.75% |
| Dec 31, 2022 | 3.16B | 407.80M | 14.84% |
| Dec 31, 2021 | 2.75B | 62.40M | 2.32% |
| Dec 31, 2020 | 2.69B | -6.60M | -0.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Ipsen News
- 12 days ago - Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) - GlobeNewsWire
- 19 days ago - Ipsen granted EU nod for Exelixis-partnered cancer drug for neuroendocrine tumors - Seeking Alpha
- 7 weeks ago - Madrigal, Ipsen, SpringWorks get EU backing for their drugs - Seeking Alpha
- 2 months ago - Ipsen S.A. - Initiation of the share buy-back program - GlobeNewsWire
- 2 months ago - Ipsen S.A. - Annual General Meeting held on 21 May 2025 - GlobeNewsWire
- 3 months ago - Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting - GlobeNewsWire
- 4 months ago - Ipsen S.A. (IPSEY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Ipsen S.A. reports Q1 results - Seeking Alpha